James Quigley

Insider Reports History

Entity
Individual
Location
Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge, MA
Signature
Barry Schachter for James Quigley
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Quigley:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HESS CORP Director Common Stock, $1.00 par value 20K $2.93M $146.16 Mar 6, 2024 Direct

Insider Reports Filed by James Quigley

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HES HESS CORP Mar 6, 2024 1 $0 4 Mar 8, 2024 Director
HES HESS CORP Jun 2, 2023 1 $0 4 Jun 5, 2023 Director
HES HESS CORP Mar 6, 2023 1 $0 4 Mar 8, 2023 Director
HES HESS CORP Mar 6, 2022 1 $0 4 Mar 8, 2022 Director